Arcinova Aseptic Development & Manufacturing Capabilities Info Sheet

At Arcinova, our innovative approach enables rapid development and manufacturing of sterile solution formulations for parenteral administration, with a strong emphasis on environmental and process controls. Our expertise lies in the development of parenteral drug products, from candidate development through to clinical trial manufacturing via aseptic filtration techniques.

We can develop, manufacture, test, release, and supply a range of formulations, such as intravenous (IV), subcutaneous (SC), and intramuscular (IM) administration for a variety of clinical study types (e.g., first-in-human studies and human ADME studies.)